Top Industry Leaders in the Valley Fever Market
Latest Valley Fever Companies Updates:
NIH awards $8 million grant to develop Valley Fever vaccine This December 2023 grant funding from the National Institutes of Health (NIH) supports the development of a potential Valley Fever vaccine by researchers at the University of Arizona.
New rapid diagnostic test shows promise for early detection A collaborative effort between researchers at UCSF and UC Berkeley has developed a promising new rapid diagnostic test for Valley Fever, potentially enabling quicker diagnosis and earlier treatment interventions.
Valley Fever Solutions secures $14 million Series A funding This venture capital funding will support the development and potential commercialization of Nikkomycin Z, a promising antifungal drug candidate for Valley Fever treatment.
Arizona biotech companies collaborate on Valley Fever research Several Arizona-based biotechnology companies are partnering with academic institutions and government agencies to develop new diagnostics, treatments, and preventative measures for Valley Fever.
List of Valley Fever Key companies in the market:
- Novartis
- Anacor Pharmaceuticals
- Johnson and Johnson
- Valeant Pharmaceutical
- Bristol Meyer Squibb
- GlaxoSmithKline Pharmaceuticals Limited
- Galderma S.A.
- Pfizer Inc.
